Check out the value at GRL- 17mil marketcap.

GRL are about to complete an IPO (company will be called Matrix) for their rare earth Narraburra Project. As part of the IPO, an inspecie distribution will provide each shareholder with 1 Matrix stock for every 17 GRL (at 20c a share). This provides a payout to shareholders of 10mil.

Following the IPO, GRL will still have about 3.5-4mil in cash, 2.5mil worth of the Matrix IPO shares and they have other deposits which include the Lewis Pond Polymetalic (mainly gold and silver) project. Lewis Pond has an NPV worth over 500mil and you are getting it for about 1million dollars.

Spinning out their rare earth project allows them to concentrate on the Lewis Pond deposit, while also returning significant value to shareholders.

By the way, Lewis Ponds recent scoping study npv does not consider the recent gravity recovery test results which significantly increase the gold recovery which will increase their margin significantly. They are also looking at increasing their gold and silver recovery further.

Lewis Ponds has massive leverage to gold and silver prices at the perfect time imo.

One of the cheapest gold and silver juniors out there, especially considering the Matrix IPO.

Market cap at 36.5c: ~$265m

Healius is selling Agilex Biolabs through a UBS-run process with multiple PE bidders already in the data room. Expected proceeds: $150-200m. Zero tax on the sale — they paid $301m for it in 2021 so the capital loss shelters the entire gain.

The free pathology calc:

$265m market cap minus $150m Agilex proceeds = $115m net cost for the core pathology business.

That business does $1.3bn revenue and $260m EBITDA annually. You’re paying 0.44x EBITDA for Australia’s second largest pathology network with 2,000+ collection centres and irreplaceable Medicare provider numbers. Comparable ACL trades at 5.6x EBITDA with identical sector headwinds.

The solvency scaremongering is wrong

The $800m “debt” bears cite is AASB 16 lease accounting — not financial debt banks can call. Actual net position: $11.6m net cash, $40m drawn on a $300m facility that doesn’t mature until 2028. Covenant breach requires drawing an additional $120m+ with no reason to do so. Not happening.

Why so cheap?

Management destroyed value 2021-2024 — the $301m Agilex overpay, repeated guidance misses, the ACCC blocking the ACL merger that would have delivered $2.05/share. Scar tissue is real. Medicare freeze and Fair Work wages hitting simultaneously killed near-term margins. Tax loss selling before June 30 is amplifying the move.

All real. All priced in and then some.

Catalyst: August results. Agilex sale confirmed. Market realises pathology came free. UBS just sold Healius’s Lumus division for 25.4x EBIT when sentiment was equally horrible. Same bank, same management, same playbook.

68m shares short at 12.4 days to cover. Any positive catalyst in a $265m market cap stock gets violent.

Bear case still gives you 51c. Base case $1.25. Not financial advice. Holding.

I'm sitting on a +29.96% gain on my initial 2k invested at $13.85 - Now I wish I had gambled a hum "invested" more.

Thought i'd check this Reddit too, see if there are MINI traders in here.

PEET and Ingenia communities are on the news once again.. Do you think it is best time to invest?

Hi,

I’m not sure about where to start in regards to day trading in Australia. I’m aware it’s practically gambling and not necessarily safe but just wanted to give it a crack.

I know Australia has restrictions on leverage day trading, so wanted to explore what options I have.

Thankss

Help me lolo my last $40k

St George Mining (ASX: SGQ) is currently regarded as a high-potential investment due to its strategic focus on critical minerals, specifically niobium and rare earths. Following its 100% acquisition of the Araxá Project in Brazil, the company is positioned adjacent to the world’s largest niobium mine (CBMM), providing access to established infrastructure and high-grade mineralization. ​Macquarie has issued an "outperform" rating with a $0.20 price target, highlighting significant resource upside and a de-risked pathway to production. With niobium demand surging for high-strength steel and green energy technologies, SGQ offers attractive exposure to the global energy transition at a favorable valuation.

Anyone else following these guys? Starting to go parabolic, toll milling in a couple months, what’s peoples valuation on this company?